184 related articles for article (PubMed ID: 35878747)
1. Urine phosphoethanolamine is a specific biomarker for hypophosphatasia in adults.
Shajani-Yi Z; Ayala-Lopez N; Black M; Dahir KM
Bone; 2022 Oct; 163():116504. PubMed ID: 35878747
[TBL] [Abstract][Full Text] [Related]
2. Pyridoxal 5'-phosphate and related metabolites in hypophosphatasia: Effects of enzyme replacement therapy.
Akiyama T; Kubota T; Ozono K; Michigami T; Kobayashi D; Takeyari S; Sugiyama Y; Noda M; Harada D; Namba N; Suzuki A; Utoyama M; Kitanaka S; Uematsu M; Mitani Y; Matsunami K; Takishima S; Ogawa E; Kobayashi K
Mol Genet Metab; 2018 Sep; 125(1-2):174-180. PubMed ID: 30049651
[TBL] [Abstract][Full Text] [Related]
3. Mutational and biochemical findings in adults with persistent hypophosphatasemia.
McKiernan FE; Dong J; Berg RL; Scotty E; Mundt P; Larson L; Rai I
Osteoporos Int; 2017 Aug; 28(8):2343-2348. PubMed ID: 28401263
[TBL] [Abstract][Full Text] [Related]
4. Investigation of ALPL variant states and clinical outcomes: An analysis of adults and adolescents with hypophosphatasia treated with asfotase alfa.
Kishnani PS; Del Angel G; Zhou S; Rush ET
Mol Genet Metab; 2021 May; 133(1):113-121. PubMed ID: 33814268
[TBL] [Abstract][Full Text] [Related]
5. Biochemical algorithm to identify individuals with ALPL variants among subjects with persistent hypophosphatasaemia.
Tornero C; Navarro-Compán V; Buño A; Heath KE; Díaz-Almirón M; Balsa A; Tenorio JA; Quer J; Aguado P
Orphanet J Rare Dis; 2022 Mar; 17(1):98. PubMed ID: 35241128
[TBL] [Abstract][Full Text] [Related]
6. Pyridoxine challenge reflects pediatric hypophosphatasia severity and thereby examines tissue-nonspecific alkaline phosphatase's role in vitamin B
Whyte MP; Zhang F; Mack KE; Wenkert D; Gottesman GS; Ericson KL; Cole JT; Coburn SP
Bone; 2024 Apr; 181():117033. PubMed ID: 38307176
[TBL] [Abstract][Full Text] [Related]
7. Clinical and biochemical characteristics of adults with hypophosphatasia attending a metabolic bone clinic.
Desborough R; Nicklin P; Gossiel F; Balasubramanian M; Walsh JS; Petryk A; Teynor M; Eastell R
Bone; 2021 Mar; 144():115795. PubMed ID: 33301960
[TBL] [Abstract][Full Text] [Related]
8. Clinical spectrum of hypophosphatasia diagnosed in adults.
Berkseth KE; Tebben PJ; Drake MT; Hefferan TE; Jewison DE; Wermers RA
Bone; 2013 May; 54(1):21-7. PubMed ID: 23352924
[TBL] [Abstract][Full Text] [Related]
9. Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T>C, p.M226T; c.1112C>T, p.T371I) of the tissue-nonspecific alkaline phosphatase gene.
Baumgartner-Sigl S; Haberlandt E; Mumm S; Scholl-Bürgi S; Sergi C; Ryan L; Ericson KL; Whyte MP; Högler W
Bone; 2007 Jun; 40(6):1655-61. PubMed ID: 17395561
[TBL] [Abstract][Full Text] [Related]
10. Alkaline phosphatase (tissue-nonspecific isoenzyme) is a phosphoethanolamine and pyridoxal-5'-phosphate ectophosphatase: normal and hypophosphatasia fibroblast study.
Fedde KN; Whyte MP
Am J Hum Genet; 1990 Nov; 47(5):767-75. PubMed ID: 2220817
[TBL] [Abstract][Full Text] [Related]
11. Vitamin B
Whyte MP; May JD; McAlister WH; Burgener K; Cortez SR; Kreienkamp R; Castro O; Verzola R; Zavala AS; McPherson CC; Gottesman GS; Ericson KL; Coburn SP; Arbelaez AM
Bone; 2021 Sep; 150():116007. PubMed ID: 34000433
[TBL] [Abstract][Full Text] [Related]
12. Hypophosphatasia in Adults: Clinical Spectrum and Its Association With Genetics and Metabolic Substrates.
Lefever E; Witters P; Gielen E; Vanclooster A; Meersseman W; Morava E; Cassiman D; Laurent MR
J Clin Densitom; 2020; 23(3):340-348. PubMed ID: 30655187
[TBL] [Abstract][Full Text] [Related]
13. Screening for hypophosphatasia: does biochemistry lead the way?
Held CM; Guebelin A; Krebs A; Sass JO; Wurm M; Lausch E; van der Werf-Grohmann N; Schwab KO
J Pediatr Endocrinol Metab; 2022 Feb; 35(2):169-178. PubMed ID: 34551461
[TBL] [Abstract][Full Text] [Related]
14. Bone turnover and mineral metabolism in adult patients with hypophosphatasia treated with asfotase alfa.
Seefried L; Rak D; Petryk A; Genest F
Osteoporos Int; 2021 Dec; 32(12):2505-2513. PubMed ID: 34215909
[TBL] [Abstract][Full Text] [Related]
15. Predictive modeling of hypophosphatasia based on a case series of adult patients with persistent hypophosphatasemia.
Garcia-Carretero R; Olid-Velilla M; Perez-Torrella D; Torres-Pacho N; Darnaude-Ortiz MT; Bustamate-Zuloeta AD; Tenorio JA
Osteoporos Int; 2021 Sep; 32(9):1815-1824. PubMed ID: 33619648
[TBL] [Abstract][Full Text] [Related]
16. Hypophosphatasia: An overview For 2017.
Whyte MP
Bone; 2017 Sep; 102():15-25. PubMed ID: 28238808
[TBL] [Abstract][Full Text] [Related]
17. Clinical, biochemical and genetic spectrum of low alkaline phosphatase levels in adults.
Riancho-Zarrabeitia L; García-Unzueta M; Tenorio JA; Gómez-Gerique JA; Ruiz Pérez VL; Heath KE; Lapunzina P; Riancho JA
Eur J Intern Med; 2016 Apr; 29():40-5. PubMed ID: 26783040
[TBL] [Abstract][Full Text] [Related]
18. Severe perinatal hypophosphatasia case with a novel mutation.
Yazici H; Canda E; Kalkan Ucar S; Coker M
Arch Argent Pediatr; 2022 Feb; 120(1):e21-e24. PubMed ID: 35068125
[TBL] [Abstract][Full Text] [Related]
19. Clinical Significance of Hypophosphatasemia in Children.
Bayramli R; Cevlik T; Guran T; Atay Z; Bas S; Haklar G; Bereket A; Turan S
Calcif Tissue Int; 2020 Jun; 106(6):608-615. PubMed ID: 32088736
[TBL] [Abstract][Full Text] [Related]
20. Bone healing and reactivation of remodeling under asfotase alfa therapy in adult patients with pediatric-onset hypophosphatasia.
Stürznickel J; Schmidt FN; von Vopelius E; Delsmann MM; Schmidt C; Jandl NM; Oheim R; Barvencik F
Bone; 2021 Feb; 143():115794. PubMed ID: 33301963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
